NervGen Pharma Corp.
NGENNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $149.25M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.52$6.30
- Volume (live)
- -
- Avg. volume (3M)
- 491.88K
NervGen Pharma (NGEN) Stock Price & Financial Analysis
NervGen Pharma Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.37 - $1.45 |
|---|---|
| 52-Week High | $6.30 |
| 52-Week Low | $1.52 |
| Open | $1.43 |
| Volume (last close) | 259.16K |
| Average Volume (3M) | 491.88K |
| 50-Day MA | $1.94 |
|---|---|
| 200-Day MA | $3.01 |
| 1-Year Change | −48.40% |
| Market Cap | 149.25M |
|---|---|
| Shares Outstanding | 105.10M |
| Price to Book (P/B) | 4.47 |
| EV/EBITDA | -7.23 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
NervGen Pharma at a Glance
As of the Oct 26, 2026 close, NervGen Pharma (NGEN) has a market capitalization of $149.25M.
As of its latest reported balance sheet, it holds $61.91M in cash and securities against $0.00 of debt, a net cash position of $61.91M.
NervGen Pharma does not currently pay a dividend.
The share price is down 48.4% over the past year. At $1.42 (the Oct 26, 2026 close) it sits near the bottom of its 52-week range of $1.52 to $6.30, below its 200-day moving average of $3.01.
Frequently Asked Questions About NervGen Pharma
What is the current stock price for NGEN?
As of the Oct 26, 2026 close, NGEN stock trades at $1.42. The 52-week range is $1.52–$6.30, with a day range of $1.37–$1.45.
What is the P/E ratio for NGEN?
The P/E ratio (Price-to-Earnings) for NGEN is shown in the Key Statistics section. This valuation metric helps compare NervGen Pharma Corp. to industry peers.
Does NGEN pay dividends?
NervGen Pharma does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for NGEN?
Analyst ratings and recommendations for NGEN are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of NGEN?
As of the Oct 26, 2026 close, NervGen Pharma's market capitalization is $149.2M, classifying it as a micro-cap company. NervGen Pharma operates in the Healthcare sector within the Biotechnology industry.